Modified Sodium Montmorillonite
改性钠基蒙脱石
Report date: 2023/01/01 08:30:51
NME
Base Information
Drug NameModified Sodium Montmorillonite
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhejiang Hailisheng Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesZhejiang Hailisheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A